on KLEA HOLDING (isin : FR0013481835)
Klea Holding Confirms Hypergrowth in Q3 2025
Klea Holding, a specialist in acquiring and digitalizing companies, reports a 35% increase in test volumes in Q3 2025 compared to the previous year. The company reached new revenue heights in the Health & Wellness segment in September 2025. These results come amid a strategic price increase for its Health & Wellness offerings, achieving an average test price of AED 1,580.
The group resumes work on its first digital medical centre in Saudi Arabia, anticipating an early 2026 opening. A partnership with Mobadara Investment supports this expansion. Klea confirms its 2025 goals: improved EBITDA, debt reduction via cash flow, and shareholder returns through a buyback program.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all KLEA HOLDING news